Ketamine concentrations during cardiopulmonary bypass

Canadian Journal of Anaesthesia

Volumn 43, Issue 6, 1996, Pages 580-584

  McLean, Richard F ^a,b   Baker, Andrew J ^c   Walker, Scott E ^b   Mazer, C David ^c   Wong, Bill I ^a   Harrington, Ellen M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

ANAESTHETICS, INTRAVENOUS: ketamine; PHARMACOLOGY: pharmacokinetics; SURGERY: cardiac, cardiopulmonary bypass

Indexed keywords

DIAZEPAM; FENTANYL; KETAMINE; LORAZEPAM; MIDAZOLAM; MORPHINE SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PANCURONIUM; PERPHENAZINE;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG BLOOD LEVEL; HEART OUTPUT; HEART RATE; HEMODILUTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; MALE; MEAN ARTERIAL PRESSURE; NEUROLOGICAL COMPLICATION; NEUROPROTECTION; PRIORITY JOURNAL;

EID: 0029741148     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03011770     Document Type: Article

References (28)

1. Breuer AC, Furlan AJ, Hanson MR, et al. Central nervous system complications of coronary artery bypass graft surgery: prospective analysis of 421 patients. Stroke 1983; 14: 682-7.
2. McLean RF, Wang BI, Naylor CD, et al. Cardiopulmonary bypass, temperature, and central nervous system dysfunction. Circulation 1994; 90: II 250-5.
3. Shaw PJ, Bates D, Cartlidge NEF, et al Neurologic and neuropsychological morbidity following major surgery: comparison of coronary artery bypass and peripheral vascular surgery. Stroke 1987; 18: 700-7.
4. Ribakove GH, Katz ES, Galloway AC, et al. Surgical implications of transesophageal echocardiography to grade the atheromatous aortic arch. Ann Thorac Surg 1992; 53: 758-63.
5. Blauth CI, Cosgrove DM, Webb BW, et al. Atheroembolism from the ascending aorta. An emerging problem in cardiac surgery. J Thorac Cardiovasc Surg 1992; 103: 1104-12.
6. Harrison MJG, Pugsley W, Newman S, et al. Detection of middle cerebral emboli during coronary artery bypass surgery using transcranial doppler sonography (Letter). Stroke 1990; 21: 1512.
7. Baker AJ, Naser B, Benaroia M, Mazer CD. Cerebral microemboli during coronary artery bypass using different cardioplegia techniques. Ann Thorac Surg 1995; 59: 1187-91.
8. Aberg T, Ronquist G, Tyden H, et al. Adverse effects on the brain in cardiac operations as assessed by biochemical, psychometric, and radiologic methods. J Thorac Cardiovasc Surg 1984; 87: 99-105.
9. Vaagenes P, Kjekshus J, Sivertsen E, Semb G. Temporal pattern of enzyme changes in cerebrospinal fluid in patients with neurologic complications after open heart surgery. Crit Care Med 1987; 15: 726-31.
10. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994; 330: 613-22.
11. Osuga H, Hakim AM. Relevance of interstitial glutamate to selective vulnerability in focal cerebral ischemia. J Cereb Blood Flow Metab, 1994; 14: 343-7.
12. Hoffman WE, Pelligrino D, Werner C, Kochs E, Albrecht RF, am Esch JS. Ketamine decreases plasma catecholamines and improves outcome from incomplete cerebral ischemia in rats. Anesthesiology, 1992; 76: 755-62.
13. Church J, Zeman S, Lodge D. The neuroprotective action of ketamine and MK-801 after transient cerebral ischemia in rats. Anesthesiology, 1988; 69: 702-9.
14. Marcoux FW, Goodrich JE, Dominick MA. Ketamine prevents ischemic neuronal injury. Brain Res 1988; 452: 329-35.
15. Spotoft H, Korshin JD, Sorensen Bredgaard M, Skovsted P. The cardiovascular effects of ketamine used for induction of anaesthesia in patients with valvular heart disease. Can Anaesth Soc J 1979; 26: 463-7.
16. Tuman KJ, McCarthy RJ, Spiess BD, DaValle M, Dabir R, Ivankovich AD. Does choice of anesthetic agent significantly affect outcome after coronary artery surgery? Anesthesiology, 1989; 70: 189-98.
17. Gibaldi M, Perrier D. Pharmnacokinetics. In: Swarbrick J (Ed.). Drugs and the Pharmaceutical Sciences. New York: Marcel Dekker Inc., 1975.
18. White PF, Way WL, Trevor AJ. Ketamine - its pharmacology and therapeutic uses. Anesthesiology, 1982; 56: 119-36.
19. Idvall J, Ahlgren I, Aronsen KF, Stenberg P. Ketamine infusions: pharmacokinetics and clinical effects. Br J Anaesth 1979; 51: 1167-72.
20. Domino EF, Domino SE, Smith RE, et al. Ketamine kinetics in unmedicated and diazepam premedicated subjects. Clin Pharmacol Ther, 1984; 645-53.
21. Buylaert WA, Herregods LL, Mortier EP, Bogaert MG. Cardiopulmonary bypass and the pharmacokinetics of drugs. An update. Clin Pharmacokinet 1989; 17: 10-26.
22. White PF. Comparative evaluation of intravenous agents for rapid sequence induction -thiopental, ketamine and midazolam. Anesthesiology, 1982;57: 279-84.
23. Marlow R, Reich DL, Neustein S, Silvay G. Haemodynamic response to induction of anaesthesia with ketamine/ midazolam. Can J Anaesth 1991; 38: 844-8.
24. Anis NA, Berry SC, Burton NR, Lodge D. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmac 1983; 79: 565-75.
25. Pohorecki R, Becker GL, Reilly PJ, Landers DF. Ischemic brain injury in vitro: protective effects of NMDA receptor antagonists and calmidazolium. Brain Res 1990; 528: 133-7.
26. Marietta MP, White PF, Pudwill CR, Way WL, Trevor AJ. Biodisposition of ketamine in the rat: self-induction of metabolism. J Pharmacol Exp Ther 1976; 196: 536-44.
27. Cohen ML, Trevor AJ. On the cerebral accumulation of ketamine and the relationship between metabolism of the drug and its pharmacological effects. J Pharmacol Exp Ther 1974; 189:351-8.
28. Peyton SH, Couch AT, Bost RO. Tissue distribution of ketamine: two case reports. J Anal Toxicol 1988; 12: 268-9.